Urology Department, General Hospital of Athens "G. Gennimatas", Athens.
1st Department of Urology, School of Medicine, Laiko Hospital, National and Kapodistrian University of Athens, Athens.
Arch Ital Urol Androl. 2021 Mar 19;93(1):84-85. doi: 10.4081/aiua.2021.1.84.
To the Editor, Prostate cancer (PCa) is nowadays the second most common malignancy diagnosed among men and is responsible for one of the leading causes of cancer mortality. Clinically localized disease may present with a wide variety of clinical behavior including tumors of low clinical significance as well as highly aggressive ones. Among patients treated with either radical prostatectomy or radiotherapy there is a risk of biochemical failure (BF). As a result, it is of outmost interest to develop new markers predicting the risk of BF development.
致编辑，前列腺癌（PCa）是目前男性中诊断出的第二大常见恶性肿瘤，也是癌症死亡的主要原因之一。临床局限性疾病可能表现出多种不同的临床行为，包括临床意义较低的肿瘤和高度侵袭性肿瘤。在接受根治性前列腺切除术或放疗的患者中，存在生化失败（BF）的风险。因此，开发新的标志物来预测 BF 发展的风险至关重要。
